1. Introduction
Nuclear and mitochondrial DNA constantly face oxidative DNA damage through reaction with endogenous and exogenous oxidants. 8-Oxo-7,8-dihydroguanine (8-oxoG) is the most commonly formed oxidative DNA lesion in the cell. Due to its propensity to mispair with adenines during replication, unrepaired guanine lesions can lead to mutagenesis and cellular transformation [
1,
2,
3,
4]. Furthermore, the presence of oxidized guanines in GC-rich promoter regions have been implicated in altering gene transcription, thereby impacting cellular function [
5,
6,
7,
8]. 8-oxoG is primarily excised by the base excision repair (BER) glycosylase OGG1, which localizes to both the nucleus and mitochondria [
9,
10,
11,
12,
13]. Modulation of OGG1 activity has been implicated in numerous disease pathways, including cancers [
14,
15,
16,
17,
18,
19,
20,
21] and neurological diseases such as Parkinson’s [
22,
23,
24] and Alzheimer’s disease [
1,
25,
26,
27,
28,
29]. Further, we have reported a novel role for OGG1 in regulating metabolic health. Specifically, mice with a global deletion of the
Ogg1 gene (
Ogg1−/−) are prone to both age-induced and diet-induced obesity and adiposity [
30,
31,
32].
Ogg1−/− mice display increased adipose mass along with significant increases in hepatic and serum lipids, concomitant with marked glucose intolerance, skeletal muscle atrophy, and adipocyte inflammation [
30,
31,
32]. Consistent with these findings in a mouse model, human cohort studies indicate that polymorphisms in the
OGG1 gene are directly associated with increased incidence of obesity, type II diabetes, and mortality due to cardiovascular disease [
33,
34,
35].
In contrast to obesity and glucose intolerance resulting from OGG1 deficiency, we recently reported that constitutive overexpression of mitochondrially-targeted human OGG1 significantly protected mice from high-fat diet induced obesity and adiposity [
36]. This metabolic protection was associated with key alterations in adipose tissue of OGG1-overexpressing transgenic (
Ogg1Tg) mice. Specifically, adipocyte size and markers of adipose inflammation were significantly reduced, and levels of the metabolically protective adipokine adiponectin were increased in
Ogg1Tg mice [
36]. In addition, mitochondrial content and respiration were both significantly increased in adipose tissue of
Ogg1Tg animals [
36]. Given these intriguing changes in adipose tissue of
Ogg1Tg mice, we were interested in determining if the DNA repair protein OGG1 plays a cell-intrinsic role in the adipocyte, particularly in the process of differentiation and subsequent lipid accumulation. To address this question, we used adipocytes in culture to delineate the function of OGG1 in the adipocyte for the first time. Using both the well-established 3T3-L1 pre-adipocyte fibroblast cell line, as well as stromal vascular cells isolated from
Ogg1Tg and
Ogg1−/− mice, we report here our discovery of a novel role for OGG1 in differentiation and lipid accretion in the adipocyte.
3. Discussion
OGG1 is a bifunctional DNA glycosylase belonging to the EndoIII superfamily of DNA glycosylases. Its primary substrates are 8-oxoguanine (8-oxoG) and the formamidopyrimidine derivative of guanine (FapyG) [
30,
43]. Both mouse OGG1 and human OGG1a are localized to the nucleus and mitochondria [
30,
43,
44]. However, at least in murine tissues, nuclear OGG1 activity is consistently and significantly higher than mitochondrial activity across tissues (Sampath, unpublished). Overexpression of the human
OGG1a gene downstream of the mitochondrial targeting sequence from the
MnSOD gene results in constitutive and significant overexpression of OGG1 (
Figure 4A) and has been previously reported to significantly increase mitochondrial OGG1 activity without impacting nuclear activity in diverse cell types [
36,
45,
46]. However, the construct still retains its native nuclear localization sequence, and relative increases in mitochondrial vs. nuclear OGG1 activity were not determined in the current study in adipocytes. Therefore, the effects observed in adipocytes overexpressing this construct cannot at present be attributed solely to the mitochondrial vs. nuclear effects of OGG1. Further studies using constructs that lack the nuclear localization sequence will be required to clarify potential differences.
We have previously reported that the DNA repair enzyme OGG1 plays an unexpected and novel role in the development of obesity and adiposity [
31,
32,
36].
Ogg1−/− mice are prone to diet-induced obesity and inflammation. Conversely, mice constitutively expressing human OGG1a are significantly resistant to high-fat diet induced obesity. These
Ogg1Tg mice also display significant alterations in adipose tissue metabolism, including increased levels of the adipokine adiponectin, increased mitochondrial content and function, longer and more electron-dense mitochondria in adipose tissue, and reduced adipocyte size [
36]. Given these findings in adipose tissue from
Ogg1Tg mice, we asked if OGG1 may play a cell-intrinsic role in the adipocyte. Prior to this investigation, nothing was known regarding a role for this protein in the adipocyte. Our results clearly indicate that OGG1 depletion results in accelerated adipocyte differentiation and increased lipid filling (
Figure 2). Conversely, OGG1 overexpression blunts adipocyte differentiation and lipid accretion (
Figure 3 and
Figure 4). These changes in adipocyte differentiation are evident both in primary adipocytes isolated from inguinal fat depots of
Ogg1−/− and
Ogg1Tg mice, as well as in 3T3-L1 cells overexpressing hOGG1a, thereby increasing the rigor of our findings. This is the first report indicating a role for this DNA repair protein in regulating adipocyte differentiation. Further, we show that the alterations in adipocyte differentiation are accompanied by changes in cellular protein PARylation (
Figure 5). OGG1 deficiency is associated with reduced PARylation, while OGG1 overexpression increases cellular PAR-levels. These changes are not accompanied by changes in PARP1 protein expression, and are consistent with a reported role for OGG1 in activating PARP1 in mouse embryonic fibroblasts [
38]. To our knowledge, this is also the first report of differences in PARylation in tissue extracts, particularly in adipose tissue, in mice with altered OGG1 genotype.
In addition to OGG1, the BER glycosylase NEIL1 has also been reported to bind to and activate PARP1 [
47]. While we did not observe any changes in
Neil1 expression during the adipogenic process, a similar obesity susceptibility phenotype has been reported in mice lacking NEIL1 [
48,
49]. Thus, it will be of interest to determine if NEIL1 inhibition is also associated with increased adipocyte differentiation and lipid accretion, analogous to OGG1 inhibition. It is also of interest to note that of the BER glycosylases examined,
Neil3, showed a similar pattern of expression as
Ogg1 during the adipogenic process (
Figure S1). Both genes were upregulated at early time points, unlike other glycosylases measured. NEIL3 is a bifunctional DNA glycosylase with broad substrate specificity and activity against both oxidized purines and pyrimidines, but not 8-oxoG. NEIL3 has been shown to excise further oxidized products of 8-oxoG, including spiroiminodihydantoin (Sp) and guanodinohydantoin [
50,
51]. Virtually nothing is known regarding a potential role for the NEIL3 glycosylase in modulating adipogenesis or metabolic function. However, the similar regulation of both
Ogg1 and
Neil3 in differentiating adipocytes suggests a potentially novel role for NEIL3 in adipogenic differentiation and perhaps in adipose tissue function.
Our studies indicate an inverse correlation between cellular PARylation levels and adipogenic differentiation capacity, as well as obesity resistance. There are conflicting reports regarding the role of PARP1 activity in regulating body weight. Two different models of whole body PARP1 deletion reported opposing results regarding either protection from or exacerbation of obesity as a consequence of PARP1 deletion [
40,
52], while a more recent report indicated that PARP1 ablation only in preadipocytes resulted in the development of obesity [
41]. The reasons for these discrepancies are not yet clear, but may be related to the genetic background of the animal model and tissue-specific differences in the consequences of PARP1 deletion, with regard to whole animal metabolism [
53]. Our studies demonstrate that the increased propensity to obesity in
Ogg1−/− mice is associated with reductions in PARP1 activity, while obesity resistance in
Ogg1Tg animals is associated with increased cellular PARylation. We also note that these apparent changes in PARP1 activity are evident not only in white adipose tissue, but also in other metabolically active organs, such as brown adipose tissue and liver (
Figure S3). The role of altered cellular PARylation in mechanistically mediating the metabolic phenotypes of
Ogg1−/− and
Ogg1Tg mice are yet to be elucidated.
Separately from the issue of body weight regulation, PARP1 has also been demonstrated to influence adipogenesis [
41]. A previous report indicated that inhibition of PARP1 either via siRNA-based depletion or by chemical inhibition resulted in increased adipocyte differentiation and lipid accretion [
42]. This was mediated by alterations in PARylation of the early adipogenic factor, CEBPβ, which regulates subsequent expression of factors such as CEBPα and PPARγ [
42], both of which are modulated differentially by OGG1 status (
Figure 2,
Figure 3 and
Figure 4). A more recent report indicated that activation of PARP1 by small nucleolar RNA inhibited adipogenesis [
41]. Together with these results, our findings of increased cellular PARylation in
Ogg1Tg adipocytes that differentiate less effectively and decreased PARylation in
Ogg1−/− adipocytes that accumulate more lipids are suggestive of an inhibitory role for PARP1 activity in adipogenesis.
In summary, using both primary adipocytes from Ogg1−/− and Ogg1Tg mice, as well as 3T3-L1 cells transfected in culture, our studies establish for the first time a novel role for the DNA repair protein OGG1 in modulating adipocyte differentiation and lipid accumulation. These results are consistent with previous reports of obesity susceptibility in OGG1-deficient mice, decreased lipid accumulation in mice overexpressing OGG1, and reported correlations between OGG1 polymorphisms and obesity in human cohorts. They thus add to our growing understanding of the role of this protein in regulating metabolic homeostasis.